Connect with us

Health

FDA advisers debate standards on a coronavirus vaccine for young children – The Washington Post

Executives from Pfizer and Moderna have said that data showing whether their vaccines are effective in younger children are expected…

Published

on

Article feature image

The discussion was not centered on a particular vaccine, and it unfolded as Pfizer-BioNTech and Moderna conduct trials of their vaccines in children.
The Pfizer-BioNTech vaccine is already authorized for adolescents as young as 12, and Moderna announced…

Click here to view the original article.